Physicians and patients seek cancer susceptibility genetic testing to mitigate potential risks and seek early interventions. Clinical molecular laboratories looking to expand their assays to meet these needs must take into account the requirements related to technical aspects of testing, patient populations, genetic counseling support, and reimbursement.
Download this guide from Velsera to learn how laboratories navigate hereditary cancer testing in the context of clinically relevant scenarios.
Top Image Credit:
iStock
A neurobiologist, who loves the morphology of cells, turns these shapes into works of art made from wood.
View this Issue
Explore the latest in cell culture supplies, from tried and tested classics to cutting-edge innovative products.
Explore the latest in cell culture supplies, from tried and tested classics to cutting-edge innovative products.
In this webinar, Jesús Tintos-Hernandez, Setsu Endoh-Yamagami, and Amaris Castañon will discuss the latest advances and innovations in neuroscience disease cell models.
Within the tumor microenvironment, networks of cells and molecular signals form a dynamic landscape that drives disease progression.
This partnership will enable both companies to reach a broader range of customers, including those with more complex and specialized workflows
Submit a cutting-edge product or technology for the chance to be recognized as one of The Scientist’s 2026 Top Innovations.
Biotium's new TyraMax™ Amplification Dyes and Kits are available with the widest selection of colors for spatial analysis
Ten-year Agreement to Provide a Secure, AI-enabled Forensic Laboratory Information Management System Supporting DHS Forensic, Scientific, and Testing Services
